Cargando…
Applicability of RPMI 2650 and Calu-3 Cell Models for Evaluation of Nasal Formulations
The RPMI 2650 and Calu-3 cell lines have been previously evaluated as models of the nasal and airway epithelial barrier, and they have demonstrated the potential to be used in drug permeation studies. However, limited data exist on the utilization of these two cell models for the assessment of nasal...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877043/ https://www.ncbi.nlm.nih.gov/pubmed/35214101 http://dx.doi.org/10.3390/pharmaceutics14020369 |